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examined the association between the immune status and
the psychological (perceived) stress in patients with chronic
hepatitis B, and the involvement of cortisol.
Methods: Forty patients with chronic hepatitis B com-
pleted the Perceived Stress Scale-14 (PSS-14) and State-Trait
Anxiety Inventory (STAI-Form). These two scales are self-
report questionnaires to measure psychological stress, state
anxiety and trait anxiety. We measured two types of T cell-
derived cytokines level (IL-10 and IFN) and plasma cortisol.
Correlation analysis was employed to explore the relation-
ship among psychological scores, cortisol and cytokine level.
Results: Our results show that the level of IL-10 was
related to psychological stress (P = 0.03), state anxiety
(P = 0.01) and trait anxiety (P = 0.03). No correlations were
found between psychological stress and IFN-  levels. Also
no correlations were developed between cortisol and psy-
chological stress, anxiety, IL-10, and IFN- .
Conclusion: From the results, it can be concluded that
psychological stress depresses the immune reaction in
patients with chronic hepatitis B, which is disadvantage
of HBV r esolve. Those patients were in great need of
psychological support. Cortisorl plays little role between
psychological stress and immune state in patient with hep-
atitis B.
doi:10.1016/j.ijid.2008.05.1099
67.009
Association Between HLA-A, B, DRB1 Alleles and Suscep-
tibility or Resistance to Chronic Hepatitis B
A. Ramezani1,∗, M.R. Hasanjani Roshan2, E. Kalantar3, A.
Eslamifar1, M. Mohraz4, M. Banifazl 5, A. Aghakhani1, J.
Taeb1, A.A. Velayati 6
1 Pasteur Institute of Iran, Tehran, Iran (Islamic Republic of)
2 Babol University of Medical Sciences, Babol, Iran (Islamic
Republic of)
3 School of allied medical sciences, Iran medical university,
Tehran, Iran (Islamic Republic of)
4 Iranian Research Center for HIV/AIDS, Tehran, Iran (Islamic
Republic of)
5 Iranian society for support patients with infectious dis-
ease, Tehran, Iran (Islamic Republic of)
6 Masih Daneshvari Hospital, Tehran, Iran (Islamic Republic
of)
Objective: Hepatitis B virus (HBV) infection is a major
public health problem worldwide. The mechanism of sus-
ceptibility to chronic persistent HBV infection is not well
clariﬁed, while the outcome of HBV infection mainly
depends on the host immune response. Different HLA class
I and II alleles may play roles in HBV infection outcome. In
this study, the association between HBV infection and HLA
alleles was studied.
Methods: HLA-A, B and DRB1 alleles in 33 patients with
chronic hepatitis B and 31 healthy carriers collapsed as
persistent group, and 30 subjects who had spontaneously
recovered from HBV infection were analyzed by using PCR-
sequence speciﬁc primer (PCR-SSP) technique
Results: The frequency of HLA-A*33 allele was higher in
persistent group than recovered group (P < 0.008); the fre-
quency of DRB1*13 allele was lower in persistent group than
in recovered group (P < 0.03). The frequency of B*52 allele
was higher in CHB patients than healthy carriers (P < 0.05).
Conclusion: HLA-A*33 was related with susceptibility and
HLA-DRB1*13 was related with protection against persis-
tency of hepatitis B. Our survey also showed that the
frequency of B*52 allele was higher in CHB patients than
healthy carriers which further conﬁrmed the role of HLA
alleles in clinical presentations of HBV infection. The above
results suggest that host HLA class I and II alleles are
important factors in determination of the outcome of HBV
infection.
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Objective: Hepatitis B (HB) vaccine is effective in produc-
ing protection against HB virus infection in hemodialysis (HD)
patients, but the persistence of immunity remains largely
unknown. In this study we aimed to evaluate the persistence
of hepatitis B vaccine immunity in HD patients.
Methods: In this study we had followed 54 HD patients up
to 1 year after primary hepatitis B vaccination [four doses
vaccination schedule 40g injections intramuscularly in the
deltoid muscle at 0,1,2,6 months] to evaluate the persis-
tence of immunity [as indicated by serum levels of antibody
to hepatitis B surface antigen (anti-HBs) higher than or equal
to 10 IU/l]
Results: At 1 year after vaccination, 18.18% of patients
had lost their anti-HBs (transient responders) while 81.82%
of them had detectable antibody in the serum (persistent
responders). From 81.82% of persistent responders 11.5%
and 88.5% were weak and high responders respectively.
There was no signiﬁcant difference between persistent
and transient responders regarding age, sex and nutritional
factors (serum albumin, triglycerides, and cholesterol),
hemoglobin, parathyroid hormone (PTH), fasting blood sugar
(FBS), C3, C4 and anti-HCV.
Conclusion: Our study supported this fact that an anti-
body titer above 100 IU/l following primary vaccination is
necessary in order to maintain that level of antibody 1 year
later.
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